DBV TECHNOLOGIES SA (DBV.DE) Fundamental Analysis & Valuation

FRA:DBV • FR0010417345

Current stock price

3.618 EUR
+0.14 (+4.12%)
Last:

This DBV.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DBV.DE Profitability Analysis

1.1 Basic Checks

  • DBV had negative earnings in the past year.
  • DBV had a negative operating cash flow in the past year.
  • DBV had negative earnings in each of the past 5 years.
  • DBV had a negative operating cash flow in each of the past 5 years.
DBV.DE Yearly Net Income VS EBIT VS OCF VS FCFDBV.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -85.56%, DBV is doing worse than 72.15% of the companies in the same industry.
  • DBV has a Return On Equity (-142.22%) which is in line with its industry peers.
Industry RankSector Rank
ROA -85.56%
ROE -142.22%
ROIC N/A
ROA(3y)-84.27%
ROA(5y)-75.7%
ROE(3y)-172.64%
ROE(5y)-138.93%
ROIC(3y)N/A
ROIC(5y)N/A
DBV.DE Yearly ROA, ROE, ROICDBV.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • DBV has a Gross Margin of 91.34%. This is amongst the best in the industry. DBV outperforms 83.54% of its industry peers.
  • In the last couple of years the Gross Margin of DBV has declined.
  • DBV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-2.02%
DBV.DE Yearly Profit, Operating, Gross MarginsDBV.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DBV.DE Health Analysis

2.1 Basic Checks

  • DBV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DBV has more shares outstanding
  • Compared to 5 years ago, DBV has more shares outstanding
  • The debt/assets ratio for DBV is higher compared to a year ago.
DBV.DE Yearly Shares OutstandingDBV.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DBV.DE Yearly Total Debt VS Total AssetsDBV.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • DBV has an Altman-Z score of 8.86. This indicates that DBV is financially healthy and has little risk of bankruptcy at the moment.
  • DBV has a Altman-Z score of 8.86. This is amongst the best in the industry. DBV outperforms 83.54% of its industry peers.
  • DBV has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.08, DBV is doing good in the industry, outperforming 68.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 8.86
ROIC/WACCN/A
WACC8.01%
DBV.DE Yearly LT Debt VS Equity VS FCFDBV.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • DBV has a Current Ratio of 2.45. This indicates that DBV is financially healthy and has no problem in meeting its short term obligations.
  • DBV has a Current ratio of 2.45. This is comparable to the rest of the industry: DBV outperforms 51.90% of its industry peers.
  • A Quick Ratio of 2.45 indicates that DBV has no problem at all paying its short term obligations.
  • The Quick ratio of DBV (2.45) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.45
DBV.DE Yearly Current Assets VS Current LiabilitesDBV.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DBV.DE Growth Analysis

3.1 Past

  • DBV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.66%, which is quite impressive.
  • Looking at the last year, DBV shows a very strong growth in Revenue. The Revenue has grown by 224.69%.
  • DBV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.50% yearly.
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)224.69%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%

3.2 Future

  • Based on estimates for the next years, DBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.84% on average per year.
  • The Revenue is expected to grow by 75.93% on average over the next years. This is a very strong growth
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y21.57%
Revenue Next 5Y75.93%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DBV.DE Yearly Revenue VS EstimatesDBV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
DBV.DE Yearly EPS VS EstimatesDBV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DBV.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • DBV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DBV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DBV.DE Price Earnings VS Forward Price EarningsDBV.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DBV.DE Per share dataDBV.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.4%
EPS Next 3Y10.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DBV.DE Dividend Analysis

5.1 Amount

  • No dividends for DBV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DBV.DE Fundamentals: All Metrics, Ratios and Statistics

DBV TECHNOLOGIES SA

FRA:DBV (4/8/2026, 7:00:00 PM)

3.618

+0.14 (+4.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)07-27
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)15.73M
Net Income(TTM)-122.55M
Analysts80
Price Target5.99 (65.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)48.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-91.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 310.23
P/FCF N/A
P/OCF N/A
P/B 13.68
P/tB 13.69
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.01
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -85.56%
ROE -142.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.34%
FCFM N/A
ROA(3y)-84.27%
ROA(5y)-75.7%
ROE(3y)-172.64%
ROE(5y)-138.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-2.02%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.61%
Cap/Sales 8.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 2.45
Altman-Z 8.86
F-Score2
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)25.42%
Cap/Sales(5y)23.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue 1Y (TTM)224.69%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y21.57%
Revenue Next 5Y75.93%
EBIT growth 1Y-31.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-23.2%
EBIT Next 3Y27.74%
EBIT Next 5YN/A
FCF growth 1Y0.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.02%
OCF growth 3YN/A
OCF growth 5YN/A

DBV TECHNOLOGIES SA / DBV.DE Fundamental Analysis FAQ

What is the fundamental rating for DBV stock?

ChartMill assigns a fundamental rating of 3 / 10 to DBV.DE.


What is the valuation status for DBV stock?

ChartMill assigns a valuation rating of 0 / 10 to DBV TECHNOLOGIES SA (DBV.DE). This can be considered as Overvalued.


How profitable is DBV TECHNOLOGIES SA (DBV.DE) stock?

DBV TECHNOLOGIES SA (DBV.DE) has a profitability rating of 1 / 10.